Skip to main content
. 2017 Nov 3;314(2):H311–H321. doi: 10.1152/ajpheart.00515.2017

Fig. 4.

Fig. 4.

Treatment with Exscein1-III reduces transverse aortic constriction (TAC)-induced hypertrophy. Postmortem morphological assessment of ventricular weight to tibia length (in mg/mm; A), atria weight to tibia length (in mg/mm; B), and lung weight to tibia length (in mg/mm; C) from Exscien1-III- and vehicle (Veh)-treated mice. Circles inside bars denote n values per group. D: representative images of hematoxylin and eosin-stained cardiomyocytes from Exscien1-III- and Veh-treated mice.